MRI Fluoroscopy in Heart Catheterization with Passive Guidewires
This study tests the safety and feasibility of using MRI fluoroscopy during heart catheterization with passive guidewires to gather important heart and vessel data.
MRI Heart guidewire catheterization
Congenital Abnormalities+7
+ Cardiovascular Diseases
+ Heart Defects, Congenital
Diagnostic Study
Summary
Study start date: August 2, 2017
Actual date on which the first participant was enrolled.This study investigates a new way to perform heart catheterization using MRI fluoroscopy instead of traditional X-ray guidance. Heart catheterization helps doctors measure the pressure inside the heart, but using X-rays can expose patients to radiation and doesn't show soft tissues clearly. This research is particularly important for people with heart issues because it explores a safer method that reduces radiation exposure while still providing detailed images. The study focuses on using special guidewires that won’t heat up during MRI, making it possible to perform the procedure safely. Participants in this study will undergo heart catheterization using MRI technology, where guidewires will help steer the catheters through the veins and arteries of the heart. The process involves using low-energy MRI techniques to guide the catheters without the need for X-rays. The study will evaluate how well this technique works by measuring heart function and responses during the procedure. By testing the safety and effectiveness of this method, researchers aim to refine the technique, which could eventually lead to new treatments for heart conditions without surgery.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.22 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 100 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Institutes of Health Clinical Center
Bethesda, United StatesOpen National Institutes of Health Clinical Center in Google Maps